187 related articles for article (PubMed ID: 1445924)
1. Nonlocal structural perturbations in a mutant human insulin: sequential resonance assignment and 13C-isotope-aided 2D-NMR studies of [PheB24-->Gly]insulin with implications for receptor recognition.
Hua QX; Shoelson SE; Weiss MA
Biochemistry; 1992 Dec; 31(47):11940-51. PubMed ID: 1445924
[TBL] [Abstract][Full Text] [Related]
2. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions.
Shoelson SE; Lu ZX; Parlautan L; Lynch CS; Weiss MA
Biochemistry; 1992 Feb; 31(6):1757-67. PubMed ID: 1737029
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus.
Hua QX; Shoelson SE; Inouye K; Weiss MA
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):582-6. PubMed ID: 8421693
[TBL] [Abstract][Full Text] [Related]
4. High-resolution structure of an engineered biologically potent insulin monomer, B16 Tyr-->His, as determined by nuclear magnetic resonance spectroscopy.
Ludvigsen S; Roy M; Thøgersen H; Kaarsholm NC
Biochemistry; 1994 Jul; 33(26):7998-8006. PubMed ID: 8025104
[TBL] [Abstract][Full Text] [Related]
5. A structural switch in a mutant insulin exposes key residues for receptor binding.
Ludvigsen S; Olsen HB; Kaarsholm NC
J Mol Biol; 1998 May; 279(1):1-7. PubMed ID: 9636695
[TBL] [Abstract][Full Text] [Related]
6. Hierarchical protein "un-design": insulin's intrachain disulfide bridge tethers a recognition alpha-helix.
Weiss MA; Hua QX; Jia W; Chu YC; Wang RY; Katsoyannis PG
Biochemistry; 2000 Dec; 39(50):15429-40. PubMed ID: 11112528
[TBL] [Abstract][Full Text] [Related]
7. Heteronuclear 2D NMR studies of an engineered insulin monomer: assignment and characterization of the receptor-binding surface by selective 2H and 13C labeling with application to protein design.
Weiss MA; Hua QX; Lynch CS; Frank BH; Shoelson SE
Biochemistry; 1991 Jul; 30(30):7373-89. PubMed ID: 1906742
[TBL] [Abstract][Full Text] [Related]
8. Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition.
Hua QX; Weiss MA
Biochemistry; 1991 Jun; 30(22):5505-15. PubMed ID: 2036420
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of an engineered insulin monomer at neutral pH.
Olsen HB; Ludvigsen S; Kaarsholm NC
Biochemistry; 1996 Jul; 35(27):8836-45. PubMed ID: 8688419
[TBL] [Abstract][Full Text] [Related]
10. Chiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogue.
Xu B; Hua QX; Nakagawa SH; Jia W; Chu YC; Katsoyannis PG; Weiss MA
J Mol Biol; 2002 Feb; 316(3):435-41. PubMed ID: 11866509
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of the B-chain beta-turn in [GlyB24] insulin mutants: a steady-state fluorescence anisotropy study.
Pittman I; Nakagawa SH; Tager HS; Steiner DF
Biochemistry; 1997 Mar; 36(12):3430-7. PubMed ID: 9131992
[TBL] [Abstract][Full Text] [Related]
12. Receptor binding redefined by a structural switch in a mutant human insulin.
Hua QX; Shoelson SE; Kochoyan M; Weiss MA
Nature; 1991 Nov; 354(6350):238-41. PubMed ID: 1961250
[TBL] [Abstract][Full Text] [Related]
13. Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation.
Mirmira RG; Tager HS
J Biol Chem; 1989 Apr; 264(11):6349-54. PubMed ID: 2649499
[TBL] [Abstract][Full Text] [Related]
14. How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor.
Huang K; Xu B; Hu SQ; Chu YC; Hua QX; Qu Y; Li B; Wang S; Wang RY; Nakagawa SH; Theede AM; Whittaker J; De Meyts P; Katsoyannis PG; Weiss MA
J Mol Biol; 2004 Aug; 341(2):529-50. PubMed ID: 15276842
[TBL] [Abstract][Full Text] [Related]
15. Structure and dynamics of a protein assembly. 1H-NMR studies of the 36 kDa R6 insulin hexamer.
Jacoby E; Hua QX; Stern AS; Frank BH; Weiss MA
J Mol Biol; 1996 Apr; 258(1):136-57. PubMed ID: 8613983
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of desheptapeptide(B24-B30)insulin at 1.6 A resolution: implications for receptor binding.
Bao SJ; Xie DL; Zhang JP; Chang WR; Liang DC
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2975-80. PubMed ID: 9096331
[TBL] [Abstract][Full Text] [Related]
17. Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain.
Nakagawa SH; Zhao M; Hua QX; Hu SQ; Wan ZL; Jia W; Weiss MA
Biochemistry; 2005 Apr; 44(13):4984-99. PubMed ID: 15794637
[TBL] [Abstract][Full Text] [Related]
18. Chiral mutagenesis of insulin. Contribution of the B20-B23 beta-turn to activity and stability.
Nakagawa SH; Hua QX; Hu SQ; Jia W; Wang S; Katsoyannis PG; Weiss MA
J Biol Chem; 2006 Aug; 281(31):22386-22396. PubMed ID: 16751187
[TBL] [Abstract][Full Text] [Related]
19. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
[TBL] [Abstract][Full Text] [Related]
20. A new B-chain mutant of insulin: comparison with the insulin crystal structure and role of sulfonate groups in the B-chain structure.
Dupradeau FY; Richard T; Le Flem G; Oulyadi H; Prigent Y; Monti JP
J Pept Res; 2002 Jul; 60(1):56-64. PubMed ID: 12081626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
